In the past year and a half, five studies have independently established a direct connection between the hypoxic response transcription factor, HIF-1, and aging in Caenorhabditis elegans. These studies demonstrated that HIF-1 can both promote and limit longevity via pathways that are mechanistically distinct. Here, we review the current state of knowledge regarding modulation of aging by HIF-1 and speculate on potential aspects of HIF-1 function that could be relevant for mammalian longevity and healthspan.
Introduction
Aging is a complex process that is influenced by environmental and genetic factors. Studies from yeast and invertebrate organisms have identified hundreds of genes that modulate longevity in these simple eukaryotes, and several single gene mutations have also been shown to increase lifespan in rodents (Partridge, 2009; Fontana et al., 2010; Kenyon, 2010) . Environmental components that modulate aging include temperature and diet. Indeed, the best characterized intervention for slowing aging involves reducing nutrient availability, a process referred to as dietary restriction (DR). DR has long been known to increase lifespan in organisms from yeast to rats (Masoro, 2005; Kennedy et al., 2007) and was recently shown to improve healthspan and reduce deaths due to age-related causes in the rhesus monkey (Colman et al., 2009) .
The nematode Caenorhabditis elegans has been a particularly fruitful model organism for identifying and characterizing factors that modulate aging. Several large-scale RNAi screens for enhanced lifespan in C. elegans have led to the identification of approximately 300 longevity-related genes, including many genes involved in nutrient response, mitochondrial function, chemosensation, and mRNA translation (Dillin et al., 2002; Lee et al., 2003; Hamilton et al., 2005; Hansen et al., 2005; Chen et al., 2007; Curran and Ruvkun, 2007) . Studies in C. elegans have been instrumental in defining the role of insulin-like signaling in aging, with several mutations that reduce insulin-like signaling having been shown to increase lifespan. These include loss of function alleles of insulin-like receptor daf-2 (Kenyon et al., 1993; Kimura et al., 1997; Gems et al., 1998) , the PI-3 kinase age-1 (Friedman and Johnson, 1988; Morris et al., 1996) , and Akt kinase homologs akt-1, akt-2, and sgk-1 (Hertweck et al., 2004; Hamilton et al., 2005; Oh et al., 2005) . A defining feature of these mutations and others in the insulin-like pathway is that they require the FOXO transcription factor DAF-16 in order to increase lifespan (Lin et al., 1997; Ogg et al., 1997) .
As in other organisms, DR has been studied extensively in C. elegans. Several different methods for extending lifespan through DR have been described in nematodes (Greer and Brunet, 2009; Mair et al., 2009 ). These include genetic manipulations that reduce food consumption due to a defect in pharyngeal pumping (referred to as eat mutants; Lakowski and Hekimi, 1998) , as well as environmental methods of food restriction ranging from dilution of the bacterial food source (Klass, 1977) to complete removal of the bacterial food during adulthood (Kaeberlein et al., 2006; Lee et al., 2006) . With one exception (Greer et al., 2007) , methods of DR in C. elegans extend lifespan by a mechanism that is genetically distinct from reduced insulin-like signaling, based on the observation that lifespan extension does not require Recently, oxygen availability has emerged as another important environmental factor influencing the aging process in C. elegans (Kaeberlein and Kapahi, 2009 ). In the natural environment, C. elegans are soil dwellers often found in compost. These animals probably experience oxygen concentrations ranging from atmospheric (around 20%) to only a few percent, or less. Appropriately altering cellular physiology and gene expression in response to changing oxygen availability is therefore essential for their growth and survival.
The hypoxia-inducible factor (HIF) is a highly conserved transcriptional regulator of genes necessary for the response to reduced oxygen availability, collectively referred to as the hypoxic response. HIF exists as a heterodimer of the regulated HIF-a subunit and the constitutively expressed HIF-b subunit (Wang et al., 1995) . Under normoxic conditions, HIF-a is modified by oxygen-dependent proline hydroxylases (PHDs), leading to ubiquitination by the von HippelLindau protein (pVHL) and targeted proteasomal degra- (Mehta et al., 2009; Muller et al., 2009; Zhang et al., 2009 ) define the hypoxic response as an important longevity-promoting pathway that is distinct from insulin-like signaling and dietary restriction. Three papers (Bellier et al., 2009; Chen et al., 2009; Zhang et al., 2009 ) also identify a longevity-limiting role for HIF-1 (deletion increases lifespan), but differ on the downstream mechanism. Zhang et al. (2009) report that lifespan extension from loss of HIF-1 requires DAF-16, whereas Chen et al. (2009) dation. The hydroxylation and subsequent ubiquitination reaction is inhibited by hypoxia, causing stabilization of HIF-a and induction of the hypoxic response (Kim and Kaelin, 2003) . This hydroxylation and ubiquitin-mediated regulation of HIF-a stability is conserved from nematodes to humans.
The C. elegans hypoxic response has been characterized largely through genetic and microarray studies. HIF-a is encoded by the hif-1 gene, and oxygen-dependent proteasomal degradation of the HIF-1 protein is mediated by the EGL-9 prolyl hydroxylase and the VHL-1 cullin E3 ligase subunit. Whereas EGL-9 and VHL-1 are both necessary for HIF-1 targeted degradation, EGL-9 and perhaps VHL-1 also independently regulate HIF-1 activity . Microarray and qPCR analyses show that EGL-9 downregulates HIF-1 activity in the absence of VHL-1, and vhl-1 and egl-9 transcriptional profiles differ significantly. Deletion of hif-1 causes sensitivity to hypoxia, and many mRNAs are induced by hypoxia or by deletion of either vhl-1 or egl-9 (Bishop et al., 2004; Shen et al., 2005; Mabon et al., 2009b) . Interestingly, a relationship between longevity and resistance to hypoxic stress has been noted from the fact that several mutant alleles of daf-2 confer resistance to hypoxia (Scott et al., 2002; Mabon et al., 2009a) , and a recent genome-wide RNAi screen identified 11 previously known longevity genes as regulators of hypoxia resistance (Mabon et al., 2009a) . Mehta et al. (2009) were the first to establish HIF-1 as a longevity factor by showing that stabilization of HIF-1 is associated with a significant increase in lifespan of approximately 30-50%. Stabilization of HIF-1 in this study was accomplished by RNAi knockdown or deletion of vhl-1.
Stabilization of HIF-1 increases lifespan in C. elegans
These findings were replicated in a second study of vhl-1 mutant animals (Muller et al., 2009) . Importantly, loss of vhl-1 also appeared to improve age-associated measures of healthspan in C. elegans, including resistance to amyloid b and polyglutamine toxicity, as well as accumulation of autofluorescent age pigment (Mehta et al., 2009) . Both studies of vhl-1 mutant animals established that the lifespan extension was largely dependent on HIF-1, consistent with the model that loss of vhl-1 slows aging by stabilization of HIF-1 (Figure 1 ). This model was further solidified by a third study showing that stabilization of HIF-1 by transgenic expression of a non-degradable allele is sufficient to increase lifespan ).
Although the mechanism by which stabilization of HIF-1 slows aging remains to be determined, evidence suggests that HIF-1 acts in a genetic pathway that is distinct from both insulin-like signaling and DR (Kaeberlein and Kapahi, 2009) . Lifespan extension from deletion of vhl-1 or expression of non-degradable HIF-1 occurs even in animals carrying a homozygous null allele of daf-16, and knockdown of daf-2 is sufficient to increase lifespan in hif-1 deletion mutants (Mehta et al., 2009; Muller et al., 2009; . Likewise, two different methods of DR, mutation of eat-2 and bacterial deprivation, have been shown to increase lifespan in hif-1 knockout animals (Mehta et al., 2009 ). Thus, HIF-1 and the hypoxic response appear to slow aging in a new longevity pathway that is distinct from both insulin-like signaling and DR.
In addition to knockdown of vhl-1, Mehta et al. (2009) also reported that maintaining animals under hypoxia at 0.5% oxygen is sufficient to increase adult lifespan. HIF-1 is known to be stabilized under these conditions (Jiang et al., 2001) , suggesting the hypothesis that lifespan extension from hypoxic growth occurs by a mechanism similar to lifespan extension from stabilization of HIF-1 under normoxic conditions. Although it seems likely to be at least partially correct, this hypothesis has yet to be experimentally validated.
Deletion of hif-1 increases lifespan in C. elegans
In the same study where they reported that transgenic expression of non-degradable HIF-1 increases lifespan, made the surprising observation that deletion of hif-1 can also increase lifespan. This differed from Mehta et al. (2009) , who observed no change in lifespan upon deletion of hif-1. Zhang et al. (2009) further examined the long lifespan of hif-1 deletion mutants and found that the extension was fully suppressed by mutation of daf-16. This led them to conclude that loss of hif-1 increases lifespan by a mechanism similar to reduced insulin-like signaling (Figure 1) .
A previous study from the Kapahi group had also concluded that deletion of hif-1 is sufficient to increase lifespan in C. elegans ). Unlike Zhang et al. (2009) , they reported that lifespan extension from deletion of hif-1 occurred independently of daf-16 ). They also found that hif-1 deletion failed to further extend the lifespans of animals subjected to DR or animals deleted for the S6 kinase homolog rsks-1. S6 kinase is a substrate of the target of rapamycin kinase, which is thought to act downstream of DR to promote longevity in C. elegans and a variety of other species (Hansen et al., 2008; Stanfel et al., 2009 ). Interestingly, they also found that mutation of ire-1 or knockdown of xbp-1, two factors required for the endoplasmic reticulum (ER) stress response, blocked lifespan extension from loss of hif-1 . Based on these observations, they proposed that HIF-1 acts as a negative regulator of longevity in a pathway downstream of DR and TOR signaling and upstream of the ER stress response (Figure 1) .
A more recent study by Bellier et al. (2009) has added additional confirmation that hif-1 can act as a negative regulator of longevity. In studying the role of HIF-1 in the defense against bacterial toxins they found that deletion of hif-1 led to increased lifespan, despite it being required for toxin defense (Bellier et al., 2009 ). Interestingly, they also found that animals with activated HIF-1, such as vhl-1 or egl-9 mutants, are resistant to multiple pore-forming toxins and toxic bacterial strains. It is unknown whether the resistance to bacterial toxins of vhl-1 mutant animals is related to their increased lifespan; however, at least some egl-9 loss of function mutants are not long-lived (Bellier et al., 2009; Chen et al., 2009) , suggesting that enhanced longevity does not always accompany toxin resistance.
HIF-1 and aging: consensus amid confusion
The picture that has emerged for the role of HIF-1 in aging is complex and somewhat confusing. Three independent studies have shown that stabilization of HIF-1 can increase lifespan, whereas three studies have found that deletion of hif-1 can increase lifespan. There seems to be consensus that lifespan extension from stabilization of HIF-1 occurs by a mechanism that is genetically distinct from both insulin-like signaling and DR. There is no indication to date, however, as to what that mechanism might entail. One possible explanation for HIF-1 mediated lifespan extension is that HIF-1 downregulates mitochondrial activity (Tormos and Chandel, 2010) . RNAi knockdown of several dozen mitochondrial factors has been shown to increase lifespan in C. elegans (Dillin et al., 2002; Lee et al., 2003; Rea et al., 2007) and it could be that HIF-1 activation promotes longevity via a similar mechanism. Alternatively, HIF-1 could act as a stress response factor to upregulate protection against multiple stresses, similar to other known aging modifiers such as DAF-16 and SKN-1. HIF-1 and DAF-16 are known to share a subset of target genes (McElwee et al., 2004; Hoogewijs et al., 2007) , suggesting this is a reasonable explanation. A more complete understanding of HIF-1-mediated lifespan extension will probably be accomplished through experiments characterizing factors involved in longevity-control both upstream and downstream of HIF-1.
One question that remains to be resolved is why loss of function mutations in egl-9 do not always increase lifespan. Egl-9 mutants show stabilization of HIF-1 and robust expression of HIF-1 target genes, usually exceeding that of vhl-1 mutants (Chuan Shen and Powell-Coffman, 2006; . Why then are these animals not long-lived? One possible explanation is that HIF-1 expression in egl-9 mutants exceeds a threshold that is beneficial and actually becomes detrimental -'too much of a good thing', so to speak. Consistent with this possibility, RNAi knockdown of egl-9, which only partially impairs egl-9 expression, can increase lifespan and enhance resistance to polyglutamine and amyloid b toxicity (Mehta et al., 2009) . It is also possible that pleiotropic effects associated with mutation of egl-9, but not vhl-1, limit longevity in a manner that prevents lifespan extension from HIF-1 stabilization in these animals. For example, egl-9 mutants have a defect in egg laying that is not apparent in vhl-1 deletion animals (Trent et al., 1983; Epstein et al., 2001) .
Compelling evidence has been provided for two different mechanisms for how deletion of hif-1 might be increasing lifespan. The first model, that loss of HIF-1 leads to activation of DAF-16, is satisfactory given the abundant data that DAF-16 acts as a master regulator coordinating growth, stress resistance, and longevity (Landis and Murphy, 2010) . This model is also consistent with the noted links between mutations in the insulin-like pathways and resistance to hypoxic stress (Scott et al., 2002; Mabon et al., 2009b) . DAF-16 and HIF-1 are both stress-regulated transcription factors, and there is some evidence that they have a subset of shared targets (McElwee et al., 2004; Hoogewijs et al., 2007) . One possibility is that loss of HIF-1 provides sufficient stress, even under normoxia, to induce DAF-16 and extend lifespan. If correct, future studies could shed light on the mechanism by which DAF-16 is activated and which DAF-16 target genes are involved in the enhanced longevity of hif-1 mutant animals.
The alternative model proposed by Chen et al. (2009) in which HIF-1 negatively regulates longevity downstream of TOR by repressing ER stress resistance is also intriguing. There is accumulating evidence in mammals that HIF, mammalian target of rapamycin (mTOR), and the ER unfolded protein response (UPR) interact with each other (reviewed in Wouters and Koritzinsky, 2008) . The data on TOR and HIF are somewhat mixed, but suggest that while hypoxia inhibits signaling from mTOR and lowers translation rates (Arsham et al., 2003; Sofer et al., 2005; Koritzinsky et al., 2006) , HIF-1 is preferentially translated in a TOR-dependent manner (Stein et al., 1998; Lu et al., 2004) . Both the TOR pathway and hypoxia are known to activate the UPR, and the UPR is known to protect cells from hypoxia (Romero-Ramirez et al., 2004; Bi et al., 2005) . Thus, although the mechanisms for signaling between TOR, HIF, and the UPR are not yet clear, these pathways clearly overlap and future research is likely to uncover additional links between them.
Regardless of the mechanism of lifespan extension from deletion of hif-1, the fact that loss of hif-1 is sufficient to increase lifespan under normoxic conditions is striking. Because hif-1 is not stabilized in these animals, the longevity phenotype must result from a loss of basal activity of HIF-1. Basal activity of HIF-1 in normoxia is an area that has not been adequately explored, but clearly warrants further examination.
A role for HIF in mammalian aging?
Perhaps not surprisingly, HIF function seems to be relatively simple in C. elegans compared with mammals. Current evidence suggests that worms have only one HIF transcription factor (HIF-1), one proline hydroxylase specific for HIF-1 (EGL-9), a primary HIF-1 E3 ubiquitin ligase (VHL-1) and one negative effector protein (RHY-1) (Bishop et al., 2004; Shen et al., 2005 Shen et al., , 2006 . Loss of function of any of the negative regulators of HIF-1 leads to variable increases in HIF-1 activity. In addition, all three factors are likely to have other protein targets, resulting in pleiotropic effects that, as mentioned previously with respect to EGL-9, can complicate observations Shao et al., 2009) . Despite this, it is clear that increased HIF-1 activity can lead to increased lifespan and resistance to multiple stresses including proteotoxicity (Bellier et al., 2009; Mehta et al., 2009; Budde and Roth, 2010) . It is also clear that, in at least certain conditions, loss of HIF-1 function under normoxic conditions leads to increased lifespan and resistance to certain stresses (Bellier et al., 2009; Zhang et al., 2009 ). The seemingly paradoxical idea that C. elegans maintain HIF-1 levels at suboptimal levels for lifespan and stress resistance can arise from differences between the laboratory conditions used to study C. elegans and their natural environment or could be due to currently unappreciated selective advantages associated with this mode of HIF-1 regulation.
Whereas the hypoxia response system is relatively simple in worms, the mammalian system is much more complex. There are three HIFa proteins in mammals , the first two of which are known to activate an overlapping but distinct set of genes (Schofield and Ratcliffe, 2004; Koh et al., 2008) . Although there is only one known HIF ubiquitin ligase in mammals (pVHL), there are three proline hydroxylases (PHD-1, PHD-2, and PHD-3), and a myriad of other possible effectors of HIF function.
Also, because mammals have much less surface area to volume than worms, cellular oxygen tension is much lower in mammals and is under homeostatic control. Thus, mammalian hypoxic response is important for both cellular and systemic response to changing oxygen conditions (Koh et al., 2008) .
HIF-1a in mammals was discovered by its ability to increase production of erythropoietin (Wang et al., 1995) , but was quickly linked to the hereditary syndrome, VHL disease (Kaelin, 2002) . This heterozygous disease is characterized by development of angiomas in the retina and central nervous system and carcinomas in the kidneys (Kaelin, 2002) . Because HIF-1a increases are involved in VHL disease and are a frequent negative predictor in metastatic tumors (Semenza, 2009) , there is little data on the role of HIF-1a in mammalian aging. It is clear that globally disrupting pVHL function in mammals is unlikely to increase lifespan as it does in worms, and it is also clear that knocking-out HIF-1a or HIF-2a in mammals will not show enhanced lifespan, because both proteins are necessary for development (Iyer et al., 1998; Ryan et al., 1998) . Therefore, the relationship between HIF-1a regulation and aging will be more complicated to discern in mammals than in C. elegans.
Despite the complexities involved, there are signs that HIF-1a can play an important role in mammalian aging. Studies have shown that HIF-1a protein levels increase with age, perhaps due to increased hypoxia or increased oxidative stress, but that this increase is mitigated by DR (Kim et al., 2002; Kang et al., 2005) . Interestingly, one of these studies showed increased HIF-1a binding to HIF-1 responsive elements in young dietary restricted mice, which was stable over time, suggesting that preemptive HIF-1a increases can help prevent age-associated damage. Another study examining PHD3 in rats found that PHD3 levels increase with age in liver, heart, and skeletal muscle, and that this increase correlates with a decrease in HIF-1a activity (Rohrbach et al., 2008) . DR was able to mitigate the increase in PHD3 levels and maintain HIF-1a activity in aged rats, raising the possibility this activity could be involved in the protective effects of DR.
A separate study showing that HIF-1a activity improves the inotropic responses of aged cardiac myocytes (Tan et al., 2010) further suggests a role for HIF-1a in resistance to agerelated disease. Many other age-related diseases, including Alzheimer's disease, Parkinson's disease, and diabetes, involve hypoxic conditions that can worsen the disease. Studies examining amyloid b accumulation in Alzheimer's disease suggest that increased HIF-1a tends to be protective in disease-free states, but that increased HIF-1a levels are also a sign of advanced disease progression (Ogunshola and Antoniou, 2009 ). This seemingly contradictory data could stem from the role of HIF-1a in stress response, in that its upregulation can be either protective or reactive in nature, and the context of measurement is important (Ogunshola and Antoniou, 2009) .
Recent studies have linked mammalian HIF to another aging-related group of proteins, the sirtuins. Sirtuins are a family of NAD-dependent protein deacetylases named for their founding member yeast Sir2. Overexpression of Sir2 was first shown to increase replicative lifespan in yeast (Kaeberlein et al., 1999) , and Sir2 orthologs have been subsequently shown to similarly modulate longevity in worms (Tissenbaum and Guarente, 2001 ) and flies (Rogina and Helfand, 2004) . Although activation of mammalian sirtuins has not been found to increase lifespan, the mouse Sir2 ortholog SIRT1 has been linked to multiple age-related diseases (Finkel et al., 2009) , and knockout of a second Sir2 homolog SIRT6 results in genomic instability and phenotypes resembling accelerated aging (Mostoslavsky et al., 2006) . Dioum et al. (2009) reported that SIRT1 can bind and deacetylate HIF-2a in order to promote HIF activation in response to hypoxia. The authors suggest that HIF-2a is more responsive to subtle changes in oxygen than HIF-1a, and that SIRT1 is necessary for its activation and 'fine-tuning' of the hypoxic response. A separate study by Zhong et al. (2010) suggests that HIF-1a is regulated by SIRT6. The authors contend that SIRT6 deacetylates histones near HIF-1a target genes, deactivating their promoters. They provide evidence that the extreme hypoglycemia of SIRT6 knockout mice results from cellular glucose uptake caused in large part by HIF-1a activation. This research not only links HIF to an important aging-related protein family but suggests another potential therapeutic role for HIF-1a activation by enhancing glucose clearance in age-related diseases such as type II diabetes.
In summary, the data to date indicate that the hypoxic response is a promising new avenue for aging research. In just a year since the first published paper on HIF-1 and aging in C. elegans, multiple studies have confirmed and extended the initial work and have suggested that HIF-1 plays a central role in worm aging. Although the role of HIF in mammalian aging and age-related disease will surely have increased complexity, we are optimistic that the lessons learned from C. elegans will provide insight into this problem. Further studies on the mechanism(s) by which HIF-1 acts as both a positive and negative regulator of longevity in worms should provide a better understanding of the pathways involved and a potential starting point for more detailed mammalian studies and, perhaps, therapeutic modulation of HIF activity.
